ginkgolide b has been researched along with ketanserin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Battaglia, C; Buono, C; Chiariello, M; Cirillo, P; Condorelli, M; Formisano, S; Golino, P; Pacifico, F; Ragni, M | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
3 other study(ies) available for ginkgolide b and ketanserin
| Article | Year |
|---|---|
Activated platelets and leucocytes cooperatively stimulate smooth muscle cell proliferation and proto-oncogene expression via release of soluble growth factors.
Topics: Animals; Cell Division; Coculture Techniques; Diterpenes; Fibrinolytic Agents; Gene Expression; Genes, fos; Ginkgolides; Growth Substances; Ketanserin; Lactones; Leukocytes; Muscle, Smooth, Vascular; Pentanoic Acids; Platelet Activation; Pyridines; Rabbits; Receptors, Platelet-Derived Growth Factor; Receptors, Thromboxane; Selective Serotonin Reuptake Inhibitors; Trapidil | 1999 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |